Anabelle Colaco
18 Nov 2026, 01:15 GMT+10
NEW BRUNSWICK, New Jersey: Johnson & Johnson has agreed to buy Texas-based biotech Ollin Biosciences for up to US$3.33 billion, the company said on November 16, betting on an experimental eye drug to build its presence in a field where it has a limited footprint despite its large contact lens business.
The buyout includes an upfront $2.2 billion and potential regulatory and commercial milestone payments of up to $1.13 billion, J&J said. It is expected to close by year-end.
Ollin's experimental treatment, OLN324, is being developed to treat diabetic macular edema (DME) and wet age-related macular degeneration (AMD), two leading causes of vision loss. Together, they affect more than 40 million people worldwide, J&J estimated.
In a recent early-stage head-to-head study, the drug showed faster and greater improvements in eye structure and greater vision gains in both DME and wet AMD than Roche's Vabysmo, Ollin said.
"Johnson & Johnson has established strong credentials in ophthalmology with surgical vision equipment and vision care (primarily ACUVUE contact lenses), making this a logical strategic fit," said RBC Capital Markets analyst Trung Huynh.
J&J also said it would enter into a separate agreement with Blackstone Life Sciences for $750 million in multi-year funding for the late-stage development of OLN324, in exchange for some payments and royalties.
Earlier this month, Pfizer said Blackstone would provide up to $1.5 billion through 2028 to help fund the development of an experimental monthly obesity treatment.
Ollin, backed by investment firms ARCH Venture Partners and Mubadala Capital, was established in 2023 to develop treatments for vision-threatening diseases. Its pipeline includes OLN102, currently in preclinical development, for thyroid eye disease and Graves' disease.
The biotech raised $330 million in June to fund late-stage trials of OLN324.
Get a daily dose of Milwaukee Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Milwaukee Sun.
More InformationDUBAI/MANILA: U.S. President Donald Trump said on November 17 that his government was taking seriously intelligence reports suggesting...
AMMAN, Jordan: Jordan will block the Telegram messaging app nationwide over national security concerns, authorities announced on November...
MOSCOW, Russia: Russia said it had intercepted 1,336 Ukrainian drones in a single day, marking the highest number of claimed drone...
LONDON, U.K.: Thousands of women in Britain who faced criminal investigations or convictions for ending their pregnancies under an...
WASHINGTON, D.C.: A router installed by government contractor L3Harris triggered the communications failure behind the longest nationwide...
WASHINGTON/BEIJING/MOSCOW: US President Donald Trump, Chinese President Xi Jinping and Russian President Vladimir Putin could meet...
DUBAI/MANILA: U.S. President Donald Trump said on November 17 that his government was taking seriously intelligence reports suggesting...
AUSTIN, Texas: Tesla is inviting select customers to buy its Cybercab two-seater for personal use, at a price of $29,990 plus an Autonomy...
WASHINGTON, D.C.: US safety regulators have urged owners of more than 720,000 BMW vehicles to park outside until repairs can be completed,...
WASHINGTON, D.C.: Sales of previously owned US homes fell in October to their lowest level in more than 16 years, as rising mortgage...
(Photo credit: Charles LeClaire) The Boston Red Sox traded left-hander Raymond Burgos to the Athletics on Tuesday for minor league...
(Photo credit: Charles LeClaire) The Boston Red Sox traded left-hander Raymond Burgos to the Athletics on Tuesday in exchange for...
